Notice2021-17821
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 19, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 158 (Thursday, August 19, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 158 (Thursday, August 19, 2021)]
[Notices]
[Pages 46707-46708]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-17821]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Clinical Trials and Translational Research Advisory
Committee.
The meeting will be held as a virtual meeting and is open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the
[[Page 46708]]
Contact Person listed below in advance of the meeting. The meeting will
be videocast and can be accessed from the NIH Videocasting and
Podcasting website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>).
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee.
Date: November 10, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: Strategic Discussion of NCI's Clinical and Translational
Research Programs.
Place: National Cancer Institute, 9609 Medical Center Drive,
Rockville, MD 20850 (Virtual Meeting).
Contact Person: Sheila A. Prindiville, M.D., M.P.H., Director,
Coordinating Center for Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical Center Drive, Room
6W136, Rockville, MD 20850, 240-276-6173, <a href="/cdn-cgi/l/email-protection#97e7e5fef9f3fee1e4d7faf6fefbb9f9feffb9f0f8e1"><span class="__cf_email__" data-cfemail="3747455e59535e4144775a565e5b19595e5f19505841">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm">http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17821 Filed 8-18-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 19, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.